METHAMPEX Drug Patent Profile
✉ Email this page to a colleague
When do Methampex patents expire, and when can generic versions of Methampex launch?
Methampex is a drug marketed by Teva and is included in one NDA.
The generic ingredient in METHAMPEX is methamphetamine hydrochloride. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methamphetamine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Methampex
A generic version of METHAMPEX was approved as methamphetamine hydrochloride by DR REDDYS LABS SA on April 21st, 2010.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METHAMPEX?
- What are the global sales for METHAMPEX?
- What is Average Wholesale Price for METHAMPEX?
Summary for METHAMPEX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 60 |
| Patent Applications: | 1,763 |
| DailyMed Link: | METHAMPEX at DailyMed |
US Patents and Regulatory Information for METHAMPEX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva | METHAMPEX | methamphetamine hydrochloride | TABLET;ORAL | 083889-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
